@Article{biocell.2021.014621,
AUTHOR = {YASHVI SHARMA, SUCHI GUPTA, SUJATA MOHANTY},
TITLE = {Mesenchymal stem cell-derived exosome as a nano weapon to target the COVID-19 pandemic},
JOURNAL = {BIOCELL},
VOLUME = {45},
YEAR = {2021},
NUMBER = {3},
PAGES = {517--520},
URL = {http://www.techscience.com/biocell/v45n3/41695},
ISSN = {1667-5746},
ABSTRACT = {In these times of despair when a nano-sized organism, the SARS-CoV-2, has rendered the human race helpless,
made the global health status decline, and drowned the world economy, a ray of hope comes from another nano-sized
particle, the exosome. The potential of mesenchymal stem cells has already been established in COVID-19; however,
cell-based therapy has its risks. We thereby propose cell-free therapy using stem cells-derived exosomes to fight
against COVID-19, as they can be a game-changer owing to their immunomodulatory nature, which combats the
cytokine storm characterizing this disease, and their practical efficiency, which will realistically aid large access to
therapy worldwide.},
DOI = {10.32604/biocell.2021.014621}
}